Atrial Fibrillation Devices Market Size Forecast: $13.28 Billion by 2029 | Global Outlook

"Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.

What Is the Projected Market Size Valuation of the Atrial Fibrillation Devices Market by 2025?
The market size for atrial fibrillation devices has seen a quick expansion in recent years. It is expected to increase from $7.69 billion in 2024 to $8.60 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.8%. The growth observed in the historic period is predominantly due to factors such as an increase in the elderly population, a surge in demand for less invasive cardiac procedures, the expansion of government initiatives, and the increased access to telecardiology services.

What Is the Estimated Market Growth Value for the Atrial Fibrillation Devices Industry in 2029?
In the forthcoming years, the atrial fibrillation devices market is predicted to undergo fast-paced expansion. The market size is projected to escalate to $13.28 billion by 2029, surging at a compound annual growth rate (CAGR) of 11.5%. This market growth during the projected period is linked to factors such as increased spending in healthcare, a growing number of multi-specialty hospitals, a rising inclination towards advanced treatment options, increasing regulatory approvals for devices, and growing preference for minimally invasive surgical procedures. Key trends during this forecast period consist of technological advancements, evolutions in remote monitoring devices, the incorporation of artificial intelligence in diagnosis procedures, development strides in minimally invasive ablation mechanisms, and progress in mapping and imaging technologies.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report

What Are the Growth Drivers and Opportunities in the Atrial Fibrillation Devices Market?
The escalation of cardiovascular diseases is predicted to spur the expansion of the atrial fibrillation device market in the future. Disorders impacting the heart and blood vessels, including heart attacks, strokes, and hypertension, are all encompassed in cardiovascular diseases. The worldwide surge in obesity and diabetes, combined with widespread inactive lifestyles and unhealthy eating patterns, is boosting the prevalence of cardiovascular diseases. Atrial fibrillation (AFib) equipment is crucial in managing cardiovascular diseases, as they can detect, monitor, and address irregular heartbeats, which are frequently related to or caused by underlying heart problems. For example, the American Heart Association revealed data in June 2024 showing an anticipated increase in high blood pressure from 51.2% to 61.0%. It is projected that the number of individuals diagnosed with cardiovascular diseases will grow from 128 million in 2020 to over 184 million by 2050. Consequently, the rise in cardiovascular diseases is fuelling the expansion of the atrial fibrillation device market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp

What Are the Primary Segments Covered in the Global Atrial Fibrillation Devices Market Report?
The atrial fibrillation devices market covered in this report is segmented -

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices
2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products
3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies
4) By Distribution Channel: Direct Sales, Distributors, Online Sales
5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors
2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors
3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

What Are the Top Growth Trends in the Atrial Fibrillation Devices Market?
Leading corporations in the atrial fibrillation devices market are honing their focus on technological improvements, specifically on patient-centered clinical decision support resources. Their goal, to bolster diagnostic precision, tailor treatment approaches, and augment overall patient results. These resources offer digital solutions that equip healthcare professionals to customize treatment decisions based on the individual patient data. A case in point would be GE HealthCare Technologies Inc., an American medical technology corporation that introduced CardioVisio meant for Atrial Fibrillation in August 2023. This digital clinical decision tool is engineered to simplify clinician procedures while ensuring precise care for patients suffering from atrial fibrillation. It enables healthcare providers to track AFib progression, incorporating past diagnoses, treatments, medication use, and correlating complications. The platform furnishes guideline-reliant treatment recommendations, contributing to the reduction of diagnostic inaccuracies and optimizing clinical decision processes. CardioVisio collates scattered patient details into a user-friendly structure, reducing the strain on medical personnel while facilitating expedited, personalized, and efficient atrial fibrillation management.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp

Which Companies Are Shaping the Future of the Atrial Fibrillation Devices Market?
Major companies operating in the atrial fibrillation devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips N.V., Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co. Ltd., Japan Lifeline Co. Ltd., Microlife Corporation, AliveCor Inc., CardioFocus Inc., Imricor Medical Systems Inc., Kardium Inc., Stereotaxis Inc., Volta Medical, Synaptic Medical Corporation, Osypka AG, CathRx Ltd., BIOTRONIK SE & Co. KG, EP Solutions SA, CardiacSense Ltd.

Which Region Holds the Largest Market Share in the Atrial Fibrillation Devices Industry?
North America was the largest region in the atrial fibrillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out to Us
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.